Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-09-002251
Filing Date
2009-01-30
Accepted
2009-01-30 16:41:37
Documents
1
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 5 doc1.html 5  
1 FORM 5 doc1.xml 5 8772
  Complete submission text file 0001140361-09-002251.txt   10659
Mailing Address 9620 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 2402685300
REXAHN PHARMACEUTICALS, INC. (Issuer) CIK: 0001228627 (see all company filings)

EIN.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 9620 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address (240) 268-5300
Jeong Tae Heum (Reporting) CIK: 0001317190 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-34079 | Film No.: 09558825